Novartis AG Revenue From Sale Of Goods
Novartis AG (NVS) reported Revenue From Sale Of Goods of $54.53 billion for the 12-month period ending 2025-12-31, per its 20-F filed 2026-02-04.
Financial Statements › Income Statement › Other Income
ifrs-full:RevenueFromSaleOfGoods · last filed 2026-02-04
- Novartis AG revenue from sale of goods for the quarter ending 2025-06-30 was $14.05B, a 12.32% increase year-over-year.
- Novartis AG revenue from sale of goods for the quarter ending 2024-06-30 was $12.51B, a 9.40% increase year-over-year.
- Novartis AG revenue from sale of goods for the quarter ending 2023-06-30 was $11.44B, a 10.52% decline year-over-year.
- Novartis AG revenue from sale of goods for the quarter ending 2022-06-30 was $12.78B, a 1.35% decline year-over-year.
| Period end | Revenue From Sale Of Goods 3 month | Revenue From Sale Of Goods 3 month as first filed | Revenue From Sale Of Goods 6 month | Revenue From Sale Of Goods 6 month as first filed | Revenue From Sale Of Goods 12 month | Revenue From Sale Of Goods 12 month as first filed |
|---|---|---|---|---|---|---|
| 2025-12-31 | $54.53B 20-F · filed 2026-02-04 | |||||
| 2025-06-30 | $14.05B 6-K · filed 2025-07-17 | $27.29B 6-K · filed 2025-07-17 | ||||
| 2024-12-31 | $50.32B 20-F · filed 2026-02-04 | |||||
| 2024-06-30 | $12.51B 6-K · filed 2025-07-17 | $24.34B 6-K · filed 2025-07-17 | ||||
| 2023-12-31 | $45.44B 20-F · filed 2026-02-04 | |||||
| 2023-06-30 | $11.44B 6-K · filed 2024-07-18 | $13.62B 6-K · filed 2023-07-18 | $22.23B 6-K · filed 2024-07-18 | $26.57B 6-K · filed 2023-07-18 | ||
| 2022-12-31 | $42.21B 20-F · filed 2025-01-31 | $50.55B 20-F · filed 2023-02-01 | ||||
| 2022-06-30 | $12.78B 6-K · filed 2023-07-18 | $25.31B 6-K · filed 2023-07-18 | ||||
| 2021-12-31 | $42.78B 20-F · filed 2024-01-31 | $51.63B 20-F · filed 2022-02-02 | ||||
| 2021-06-30 | $12.96B 6-K · filed 2022-07-19 | $25.37B 6-K · filed 2022-07-19 | ||||
| 2020-12-31 | $48.66B 20-F/A · filed 2023-05-15 | |||||
| 2020-06-30 | $11.35B 6-K · filed 2021-07-21 | $23.63B 6-K · filed 2021-07-21 | ||||
| 2019-12-31 | $47.50B 20-F · filed 2022-02-02 | |||||
| 2019-06-30 | $11.76B 6-K · filed 2020-07-21 | $22.92B 6-K · filed 2020-07-21 | ||||
| 2018-12-31 | $44.83B 20-F · filed 2021-01-26 | $51.90B 20-F · filed 2019-01-30 | ||||
| 2018-06-30 | $11.36B 6-K · filed 2019-07-18 | $13.16B 6-K · filed 2018-07-18 | $22.29B 6-K · filed 2019-07-18 | $25.85B 6-K · filed 2018-07-18 | ||
| 2017-12-31 | $42.38B 20-F · filed 2020-01-29 | $49.11B 6-K · filed 2018-01-24 | ||||
| 2017-06-30 | $12.24B 6-K · filed 2018-07-18 | $23.78B 6-K · filed 2018-07-18 | ||||
| 2016-12-31 | $48.52B 20-F · filed 2019-01-30 | |||||
| 2015-12-31 | $49.44B 6-K · filed 2018-01-24 |